Yara International ASA
OSE:YAR
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
287.7
370.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Yara International ASA
You don't have any saved screeners yet
Okay. Good morning, and welcome to the presentation of Yara's second quarter results. Our presentation today will be by our CEO, Svein Tore Holsether; our CFO, Lars Røsæg; and our EVP Sales and Marketing, Terje Knutsen. With that, it's my pleasure to introduce Svein Tore Holsether.
Thank you very much, Tore, and good morning to all of you. We will start, as always, with safety and -- where we show a total recordable rate at 1.5 which is slightly higher than 1.4 where we were a year ago. Our performance has improved significantly over time, but we have reached a level now where we have to accept that we cannot improve at the same rate each and every month, and it is just as important to focus and to work on preventing accidents with high severity potential. I am pleased to see that the severity level of the accidents that we have had so far this year is lower than the same period last year. Still, we have had 53 accidents year-to-date, and we definitely do believe that it is possible to get to zero and we will continue to push towards that. Now let's take a look at our second quarter results. EBITDA excluding special items and IFRS 16 is up 62% year-on-year. Deliveries were up, especially for Yara-produced products, and energy costs were lower, improving our margins. Our premium product deliveries were 7% higher, which is in line with our strategy. Our earnings continue on an improving trend, as you can see on the right-hand -- on the left-hand side and so are our capital returns. But further improvement is needed in order to generate satisfactory returns and achieving this is a top priority for Yara. Yara-produced deliveries increased across all main product groups. As you can see here, our growth products generate increased volumes and revenues. This has a significant positive mix effect on our earnings as average margins for our own produced production is higher than in the rest of the portfolio. And definitely, achieving this in situation where margins are improving is of course even better. Before we go into the results, let me provide some comments on market developments this quarter. Starting with our production cost, gas prices in Europe are down 37% compared to a year earlier and U.S. gas prices were down 4% in the same period. In total, our earnings improved by $103 million in the quarter as a result of this. Nitrogen price developments were positive as prices in most locations moved up to a level where Chinese exports were again pulled into the global market. Yara's realized nitrate and NPK prices were also higher. The publication prices on the chart here are lagged by 1 month to better reflect Yara's P&L where deliveries today typically are contracted 1 month earlier. Following a year of higher investments in 2018, our investment level is significantly reduced in 2019 and 2020 as our growth products reached completion and strict capital allocation rules are enforced for any new proposals. We maintain our $1.3 billion guiding on currently committed CapEx for 2019. We have 3 major projects still under execution: Sluiskil in Netherlands with completion in second-half of this year; Salitre in Brazil with completion in first-half of 2020; and Rio Grande also in Brazil with completion end of 2020. Going forward, our priority is to deliver existing investment commitments and we have a high bar for initiating new investments and have preference for smaller high-return short payback products. I should also note that for 2021 our committed CapEx is in line with what we communicated at the Capital Markets Day.Even if we have not yet reached satisfactory return level, we are improved -- pleased to see that we are on an improving trend. This is our highest second quarter EBITDA for 4 years and our return on invested capital has improved for the last 4 quarters. I would now like to hand over to our CFO, Lars Røsæg, who will dive deeper into our financial performance. And after this, our EVP Sales and Marketing, Terje Knutsen, will provide an update on our commercial activities. Over to you, Lars.
Good morning, everybody. Let me start by the EBITDA excluding special items which landed at $546 million, representing an improvement of 62% when adjusting for also IFRS 16. The EBITDA growth is also the key driver for the increase in EPS and also for the increase in cash flow from operations, the latter which landed at $680 million, a 30% increase from 1 year ago. As communicated, reduced investment activity is currently our focus and ramping up the committed investments and CapEx at the end of the first half was consequently $490 million and committed CapEx is unchanged at $1.3 billion for the year as a total. The increase we have in earnings and in capital returns is positive and we have return on invested capital of 5% on a rolling 12-month basis. The return in the quarter in isolation was just above 7% which is positive. However, these returns are still at unsatisfactory levels and it indicates our path towards our target of a return through the cycle of above 10%. The improvements in the quarter were mainly driven by lower energy cost and increased deliveries of own produced products. We also had a positive effect from a stronger U.S. dollar, which is, of course, positive on our cost base with dollar strengthening 9% against the real and 6% against the euro. Total deliveries when excluding portfolio effects from Cubatão was flat year-on-year. The volume improvement was mainly explained by a 9% increase in Yara delivered products with higher margins than third-party products as Svein Tore also mentioned. The price margin improvement is also reflecting the increasing underlying urea prices in the quarter compared to falling underlying urea prices in the same quarter last year. The energy cost ended $103 million lower, which is in line with our guiding, and of course driven by significantly lower energy prices in Europe. The other item includes the IFRS 16 effect of $27 million and $8 million effect from Cubatão and Freeport year 1, there, of course, remembering that Cubatão came into our books in the middle of the second quarter last year. Production saw positive contributions from the growth projects and improved reliability versus the first quarter and the profit growth was driven by increased nitrogen upgrading margins in Europe. The sales and marketing segment which is less cyclical was underlying in line with last year and Terje Knutsen will give more details on that in his presentation shortly. New business is positively impacted due to increased activity in the maritime business and the Cubatão acquisition. Remaining businesses were in line with last year. Cash earnings and released operating capital funded both investments, Yara dividend payout and a net debt reduction in the quarter. The lower working capital was driven by seasonal increase of prepayments in Brazil which is special to the second quarter. The net debt EBITDA was 2.2 at the end of the second quarter, down from 2.5 at the end of 2018. As presented at our CMD last month, Yara's revised capital structure target is a mid-to long-term net debt EBITDA range of 1.5 to 2 and a net debt equity ratio below 0.6. Under this revised policy, the improved market fundamentals, combined with our extended improvement program and increased hurdle rate for new investments, may lead to increased dividend capacity beyond ordinary payout ratio going forward. Yara also repaid a $500 million bond maturity in June. And as you've seen this morning, we have renewed our RCF incorporating a link to our carbon intensity targets. We announced an extended improvement program at the Capital Markets Day, focusing on key operational metrics reported on a rolling 12-month basis to better reflect the underlying value creation. What is presented today hence contains no new targets compared to what we presented at the Capital Markets Day, but we do report on the progress as such in the second quarter. The underlying production performance increased by 346,000 tonnes versus 2018 on a rolling basis, driven by increased finished products output while ammonia was slightly down but with improved reliability compared to the first quarter. The output will vary on a quarterly basis, although the overall trend, as you can see, is positive. The main focus for us is on turnaround performance and reliability improvements, as also discussed in detail at the Capital Markets Day. We have also at this slide indicated the breakdown of the targeted volume improvements on the main product groups and we have added some supporting material in the appendix in line with what was presented at the Capital Markets Day. Going forward, we will, as mentioned, only refer to this extended improvement program with the baseline of 2018. Looking at KPIs beyond the production KPIs in the extended improvement program, energy efficiency has been negatively affected by the recent outages on larger ammonia plants, mainly done in Q1 as previously described. The fixed cost development is improving and it is worth noting that fixed costs also on a reported basis decreased for the second quarter in a row. Operating capital has increased slightly in the quarter and it is important to note that when we follow-up on this KPI we exclude prepayments. Hence, the prepayments in the second quarter in Brazil is not included in this rolling trend. And by that, I'm pleased to hand over to Terje to shed some more light on the commercial operation.
Thank you, Lars, and a very good morning to all of you. Sales and marketing increased the EBITDA with 12% compared to same quarter last year. Adjusting for the impact of the IFRS 16 and also currency, the results are in line with last year. Total deliveries increased by 2% as a 7% growth in premium products and also some small portfolio effects in Brazil more than offset the lower sales of commodities in Latin America where we have prioritized value over volume. Excluding portfolio adjustments, deliveries were slightly down compared to a strong second quarter last year. Realized prices increased for all the main product groups, although less than the commodity nitrogen prices realized in the main export hubs. Our nitrate premiums are therefore lower compared to second quarter last year. On the other hand, our NPK premiums are increasing as phosphate prices have declined. I think it's important in this context to also underline that as a distributor operating really further down into the value chain our realized prices will typically be less volatile and move slower than the price developments in export hubs. And this also underlines the resilient sales and marketing earnings. European deliveries were in line with last year, concluding the season 3% below last season. Nitrates in isolation was up 12% versus last year in the core European markets. The 23% growth in Brazil needs to be seen in light of last year's truck drivers' strike that had a significant impact on second quarter deliveries. And also worth mentioning the ongoing trade dispute between the U.S. and China supports market growth in Brazil which our second quarter deliveries clearly benefited from. Deliveries in Asia were down due to less urea trade volumes, but also some reduction in premium products following a slower demand in China compared to last year. In North America, volumes were in line with a year ago despite challenging weather conditions. Our deliveries in Latin America declined 22%, mainly by design by reducing lower margin commodity business, but also partly due to lower deliveries of premium NPKs in Colombia where deliveries in the quarter were impacted by transport strikes in the country. The increase in Africa reflects, among others, an increased trade business to Ghana. At our Capital Markets Day, we presented our long-term targets which include increasing the deliveries of premium products by more than 3.5 million tonnes by 2025 and also increasing the YaraVita deliveries to more than 100 million units also by 2025, and not at least to increase our EBITDA margin. With the performance that we have seen so far in 2019, we feel we are on track and that we can reach our long-term targets. Maybe worthwhile mentioning that when it comes to YaraVita we expect most of the increase in 2019 to come in the southern hemisphere and that's where we now are entering into season. So with this, I will hand back to Svein Tore who will give his closing remarks.
Thank you very much, Terje. As presented at our Capital Markets Day on the 26th of June, our strategic execution is concentrated on delivering improved returns as a focused company along 3 main lines: Improvement, where we are increasing our improvement targets by 70%; value, where we are increasing our sales and marketing margins by strengthening our crop-focused solutions and market positions; and growth, where we are increasing premium sales and adding revenue streams by scaling up digital farming services and developing food chain partnerships. And in order to further strengthen our strategic focus on crop nutrition, we are evaluating an IPO of our industrial nitrogen businesses. We consider our prospects attractive. First of all, we see strong industry fundamentals where growing population, as well as resource and environmental challenges, create business opportunities for Yara. In addition, the market cycle is improving with supply side pressure easing while demand looks positive with a tightening situation for grains. Our cash flow is set to improve, both due to cyclical improvement and that our CapEx is declining significantly while our earnings improvement actions deliver higher volumes and higher revenues. Finally, we have a strong competitive position with a focused and sustainable long-term strategy to improve returns through operational improvement, margin improvement and innovative growth. So with these closing remarks, I will hand back to you, Tore, to manage the Q&A session. Thank you.
Okay. We are then assembling for Q&A where all our presenters are available for questions. [Operator Instructions] So we start with Nordea.
Hans-Erik Jacobsen, Nordea. Could you give us some more detail on the sharp increase in sales on own-produced products, especially in relation to somewhat lower imports into Europe and whether the increase is sustainable?
Well, I think I will start by going back to the earlier part of the season. So it's clear that we have had increased deliveries, particularly of nitrates in Europe. We have also seen that the consequence in Brazil where we partly also are switching more of the sales of what we call YaraBasa which comes from Rio Grande has had an attractive start. This is very much in line with the priorities we have of growing the premium products. And we think if you measure this on a seasonal basis this is sustainable and according to our projected growth.
Okay. DNB next.
Eivind Veddeng from DNB Markets. Two questions, one on premiums. Can you help me understand why the nitrate premium is contracting year-on-year where the NPK premium seems to increase? And also how does the nitrate market look going into the second half of '19? Next question is on plant's reliability and downtime. Can you elaborate on plant performance in the second quarter and also going into Q3?
I'll do the second question and then I'll hand over to Terje for the premiums. When it comes to reliability as we said in first quarter we had a difficult start to the year and part of that also into April with downtime -- where significant downtime at Sluiskil, Pilbara and Tertre. The production performance in second quarter has been much better and we've produced more than last year, but still we're not at a level at all plants that we would like to be, but I'd also like to highlight that we set production records in several of our plants, and in particular I want to mention Belle Plaine which had record production both in the quarter and for the first half of the year. Going into third quarter, most of our operations are running on target, but of course, there will be volatility going into the summer months also due to higher temperatures that could impact. But at the moment, the plants are running well.
So if we take the premiums, starting with Europe and the nitrates, I think, first again to go back this season we haven't had the season where we had a very much an upswing during the last part of the season. I think we are quite satisfied with how we have been working up the price, but as you would know there is a time lag in the price setting which has a certain effect. What is very important is that the -- it's not only urea that we need to price according to, it's really the crop prices. And if you take a grain, for instance, the grain price is now at 11% below the 10-year average, which means that the farmers are under some financial constraint. Knowing that the stock of grain is low compared to that same average outside of China, I think very much will depend on the movement of grain prices going forward. When it comes to NPK, we are in much more markets. We are in much more of the high value crops segments where price typically is much more stable by design. And in those markets, we have seen lately that the DAP price is down, which means that we have been able to maintain price and or partly increase price and therefore margin.
Okay. Do we have a next question? Yes. We will go to ABG.
Bengt Jonassen, ABG. A couple questions for the CFO. On the operating capital, year-over-year seems less release than last year. Is it less prepayments into Brazil? And also on the full-year capital expenditure guidance of 1.3 year-to-date 0.5, is there downside in the guidance.? And the final question is on the bond announced today. We have seen other sectors introducing green elements in the debt financing is facing lower interest cost. Is the same valid for you compared to the previous RCF?
If I start by the CapEx for [indiscernible] second half has been slightly higher. When it comes to where we have to release, there are some effects from prepayments in Brazil [indiscernible] as I also mentioned, that's also important to take with us and that is something that we see [indiscernible] when it comes to the RCF that is natural involvement of [indiscernible] financing to our strategy and [indiscernible] that the margins on our funding into our performance on that. So we see that as a very positive contribution to our overall financing.
Other questions? There is another opportunity at 2:00 p.m. this afternoon when we have our conference call. But until then, thanks very much for attending our presentation.